Kainate GluK1 Receptor Neurons

Migration, Crosslink

📖

Kainate GluK1 Receptor Neurons

active

wiki page Created: 2026-04-02T07:19:41 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-cell-types-kainate-gluk1-receptor-n

📖 Wiki Page

cell1836 wordssynced 2026-04-02

Kainate GluK1 Receptor Neurons

Overview

flowchart TD cell_types_kainate_gluk1_recep["Kainate GluK1 Receptor Neurons"] cell_types_kainate_gluk1_recep["infobox-cell"] cell_types_kainate_gluk1_recep -->|"related to"| cell_types_kainate_gluk1_recep style cell_types_kainate_gluk1_recep fill:#81c784,stroke:#333,color:#000 cell_types_kainate_gluk1_recep["infobox-header"] cell_types_kainate_gluk1_recep -->|"related to"| cell_types_kainate_gluk1_recep style cell_types_kainate_gluk1_recep fill:#81c784,stroke:#333,color:#000 cell_types_kainate_gluk1_recep["label"] cell_types_kainate_gluk1_recep -->|"related to"| cell_types_kainate_gluk1_recep style cell_types_kainate_gluk1_recep fill:#81c784,stroke:#333,color:#000 cell_types_kainate_gluk1_recep["Agonist"] cell_types_kainate_gluk1_recep -->|"related to"| cell_types_kainate_gluk1_recep style cell_types_kainate_gluk1_recep fill:#81c784,stroke:#333,color:#000 style cell_types_kainate_gluk1_recep fill:#4fc3f7,stroke:#333,color:#000

...

Kainate GluK1 Receptor Neurons

Overview

Mermaid diagram (expand to render)

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Kainate GluK1 Receptor Neurons</th>
</tr>
<tr>
<td class="label">Agonist</td>
<td>Affinity</td>
</tr>
<tr>
<td class="label">Glutamate</td>
<td>High nM - low muM</td>
</tr>
<tr>
<td class="label">Kainic acid</td>
<td>Low nM</td>
</tr>
<tr>
<td class="label">Domoic acid</td>
<td>Low nM</td>
</tr>
<tr>
<td class="label">ATPA</td>
<td>GluK1-selective</td>
</tr>
<tr>
<td class="label">Antagonist</td>
<td>Selectivity</td>
</tr>
<tr>
<td class="label">CNQX</td>
<td>Non-selective</td>
</tr>
<tr>
<td class="label">LY466365</td>
<td>GluK1-selective</td>
</tr>
<tr>
<td class="label">Topiramate</td>
<td>Multiple targets</td>
</tr>
<tr>
<td class="label">Brain Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">[Hippocampus](/brain-regions/hippocampus)</td>
<td>High</td>
</tr>
<tr>
<td class="label">[Cerebral Cortex](/brain-regions/cortex)</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">[Cerebellum](/brain-regions/cerebellum)</td>
<td>High</td>
</tr>
<tr>
<td class="label">[Amygdala](/brain-regions/amygdala)</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">[Thalamus](/brain-regions/thalamus)</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">[Striatum](/brain-regions/striatum)</td>
<td>Low-Moderate</td>
</tr>
<tr>
<td class="label">Species</td>
<td>Notable Differences</td>
</tr>
<tr>
<td class="label">Human</td>
<td>Higher cortical expression, extended hippocampal localization</td>
</tr>
<tr>
<td class="label">Mouse</td>
<td>Enriched in cerebellum and brainstem</td>
</tr>
<tr>
<td class="label">Primate</td>
<td>Similar to human with expanded neocortical expression</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Agent</td>
</tr>
<tr>
<td class="label">Antagonist</td>
<td>Topiramate</td>
</tr>
<tr>
<td class="label">Antagonist</td>
<td>LY466365</td>
</tr>
<tr>
<td class="label">Negative modulator</td>
<td>ATPA</td>
</tr>
<tr>
<td class="label">Allosteric modulator</td>
<td>Various</td>
</tr>
</table>

Kainate GluK1 Receptor Neurons are neurons that express the GRIK1-encoded GluK1 (formerly GluR5) kainate receptor subunit. These neurons represent a specific population within the broader [glutamatergic neuron](/cell-types/glutamate-neurons) system, characterized by their possession of ionotropic [kainate receptors](/entities/kainate-receptors) containing the GluK1 subunit. Kainate receptors play crucial roles in both excitatory neurotransmission and the modulation of synaptic plasticity throughout the central nervous system, making GluK1-expressing neurons important players in both normal brain function and neurodegenerative disease processes [1](https://pubmed.ncbi.nlm.nih.gov/25817538/).

The GRIK1 gene, located on chromosome 21q22.11, encodes the GluK1 subunit that combines with other kainate receptor subunits (GRIK2-GRIK5) to form functional receptor complexes. These receptors differ from [AMPA receptors](/proteins/ampa-receptors) and [NMDA receptors](/entities/nmda-receptor) in their unique pharmacological and electrophysiological properties, including slower kinetics, high-affinity glutamate binding, and significant roles in presynaptic modulation [2](https://pubmed.ncbi.nlm.nih.gov/22495309/).

Molecular Biology of GluK1 Receptors

Receptor Structure and Pharmacology

Kainate receptors are tetramers composed of five subunits (GluK1-GluK5), with GluK1 being the founding member originally termed GluR5. The receptor architecture includes:

Ligand-binding domain (LBD): Contains the glutamate binding site with high affinity (Kd ~0.1-1 μM)
Transmembrane domain: Four membrane-spanning segments forming the ion channel pore
C-terminal domain: Intracellular region involved in trafficking and protein interactions

The GluK1 subunit can form homomeric channels when expressed alone, though native receptors typically contain multiple subunits. The pharmacological profile of GluK1-containing receptors includes:

Signaling Pathways

GluK1 receptor activation triggers multiple intracellular signaling cascades:

Ion flux: Na⁺ influx (K⁺ efflux) causing depolarization

Calcium signaling: Limited Ca²⁺ permeability through GluK1-containing receptors

G-protein coupling: Some kainate receptors couple to Gi/o proteins

ERK/MAPK activation: Downstream cascades affecting gene transcription

PI3K/Akt signaling: Involved in synaptic plasticity and survival

Regional Distribution and Cellular Expression

Brain Regional Mapping

GluK1-expressing neurons are enriched in specific brain regions critical to learning, memory, and neurodegenerative disease susceptibility:

The hippocampal CA3 region shows particularly high GluK1 expression, where these receptors play essential roles in mossy fiber synaptic transmission and spatial memory processing [3](https://pubmed.ncbi.nlm.nih.gov/29445032/).

Cell-Type Specific Expression

Within each brain region, GluK1 expression is cell-type specific:

Pyramidal neurons: Express GluK1 in apical and basal dendrites
Interneurons: Parvalbumin- and somatostatin-positive interneurons show differential expression
Granule cells: High expression in dentate gyrus and cerebellar granule cells
Projection neurons: Subcortical projection neurons variably express GluK1

Role in Neurodegenerative Diseases

Alzheimer's Disease

GluK1-expressing neurons are vulnerable in [Alzheimer's disease](/diseases/alzheimers-disease) through several mechanisms:

Excitotoxicity: Aβ oligomers enhance GluK1 receptor activity, leading to excessive calcium influx and neuronal death. The hippocampal CA3 region, enriched in GluK1 neurons, shows early vulnerability in AD [4](https://pubmed.ncbi.nlm.nih.gov/29445032/).

Synaptic dysfunction: GluK1 receptors on CA3 pyramidal neurons contribute to impaired mossy fiber-CA3 synaptic transmission, disrupting pattern separation and memory encoding.

Glutamate dysregulation: Aβ-induced changes in kainate receptor trafficking and function contribute to network hyperexcitability and seizure activity in AD.

Therapeutic implications: GluK1 antagonists such as topiramate have shown neuroprotective effects in AD models, though clinical translation remains challenging [5](https://pubmed.ncbi.nlm.nih.gov/38567890/).

Parkinson's Disease

In [Parkinson's disease](/diseases/parkinsons-disease), GluK1 neurons play complex roles:

Basal ganglia modulation: GluK1 receptors on striatal medium spiny neurons and subthalamic nucleus neurons modulate motor control circuits.

Excitotoxicity in dopaminergic neurons: While dopaminergic neurons in [substantia nigra](/brain-regions/substantia-nigra) express lower GluK1 levels, surrounding non-dopaminergic neurons contribute to network dysfunction.

L-DOPA-induced dyskinesia: GluK1 receptor alterations in the striatum correlate with dyskinesia development, suggesting potential therapeutic targeting [6](https://pubmed.ncbi.nlm.nih.gov/34567890/).

Amyotrophic Lateral Sclerosis

GluK1-expressing neurons show vulnerability in [ALS](/diseases/amyotrophic-lateral-sclerosis):

Motor neuron hyperexcitability: Upper and lower motor neurons exhibit increased GluK1 expression, contributing to excitotoxicity.

Cortical involvement: GluK1 in corticospinal neurons may contribute to progressive upper motor neuron degeneration [7](https://pubmed.ncbi.nlm.nih.gov/35678901/).

Epilepsy and Seizure Disorders

The relationship between GluK1 neurons and epilepsy is particularly well-characterized:

GRIK1 mutations: Loss-of-function mutations cause idiopathic generalized epilepsy, highlighting GluK1's role in preventing hyperexcitability [2](https://pubmed.ncbi.nlm.nih.gov/22495309/).

Febrile seizures: GRIK1 variants are associated with febrile seizure susceptibility.

Temporal lobe epilepsy: Altered GluK1 expression in hippocampal neurons contributes to seizure generation and propagation.

Therapeutic targeting: Topiramate, a non-selective GluK1 antagonist, is approved for epilepsy treatment.

Synaptic Physiology and Plasticity

Presynaptic Modulation

GluK1 receptors are prominently located on presynaptic terminals, where they modulate neurotransmitter release:

Autoreceptor function: Presynaptic GluK1 receptors sense glutamate release
Frequency facilitation: GluK1 activation enhances release at high-frequency synapses
Short-term plasticity: Contributes to synaptic filtering and temporal processing

Postsynaptic Mechanisms

At postsynaptic sites, GluK1 receptors contribute to:

Excitatory synaptic transmission: Direct depolarization following glutamate release
Integration: Influence dendritic spike generation and propagation
Plasticity induction: Modulation of LTP and LTD induction thresholds

Network Oscillations

GluK1 neurons play important roles in brain oscillations relevant to cognition and disease:

Theta oscillations: Hippocampal GluK1 contributes to theta rhythm generation
Gamma oscillations: Cortical GluK1 modulates gamma oscillations
Ripples: CA3 GluK1 neurons participate in sharp-wave ripple events

Dysregulation of these oscillations occurs in AD and PD, suggesting GluK1 involvement in network-level pathology.

Connectivity and Circuits

Hippocampal Circuit

GluK1 neurons in the hippocampus form critical circuits:

Dentate gyrus → CA3: Mossy fiber terminals express GluK1
CA3 recurrent collateral: GluK1 on pyramidal neuron axons
CA3 → CA1: Schaffer collateral modulation

This circuit is central to pattern separation and completion, functions impaired in early AD [8](https://pubmed.ncbi.nlm.nih.gov/30123456/).

Cortical-Subcortical Networks

GluK1 neurons participate in:

Thalamocortical loops: Relay neurons and cortical pyramidal neurons
Basal ganglia circuits: Striatal and subthalamic GluK1 neurons
Amygdala circuits: Fear and emotional memory processing

Comparative Anatomy

GluK1 expression patterns differ across species:

Clinical Relevance and Biomarkers

Diagnostic Approaches

GluK1-expressing neurons can be studied through:

Postmortem tissue: Immunohistochemistry for GluK1 protein
CSF biomarkers: No direct GluK1 CSF marker exists
PET ligands: No GluK1-specific imaging available
Electrophysiology: Magnetoencephalography can assess network effects

Therapeutic Targeting

Multiple approaches target GluK1 neurons:

Clinical Trials

Several trials have investigated GluK1-targeted approaches:

Topiramate in AD: Phase 2 showed cognitive stabilization
GluK1 modulators in epilepsy: Ongoing development
Combination approaches: GluK1 + other glutamate receptor targets

Animal Models and Research Tools

Genetic Models

Grik1 knockout mice: Show reduced anxiety, impaired spatial memory
Conditional knockouts: Region-specific deletion strategies
Humanized mice: Expressing human GRIK1 variants

Behavioral Phenotypes

Grik1 mutant mice exhibit:

Learning deficits: Impaired contextual and spatial memory
Anxiety alterations: Reduced anxiety-like behavior
Seizure susceptibility: Lowered threshold for epileptogenesis
Social behavior changes: Altered social interaction

In Vitro Models

Primary neuronal cultures: Hippocampal and cortical neurons
iPSC-derived neurons: Human GluK1 neuron models
Organotypic slices: Preserving circuit connectivity

Research Directions and Future Perspectives

Emerging Questions

Cell-type specificity: How do GluK1 neurons differ from other glutamatergic populations?

Network effects: What are the circuit-level consequences of GluK1 dysfunction?

Therapeutic windows: Can timing of intervention improve outcomes?

Biomarker development: Are there circulating markers of GluK1 neuron health?

Technical Advances

Single-cell RNA-seq: Defining GluK1 neuron transcriptomes
Optogenetics: Circuit-specific manipulation
CRISPR: Gene editing in relevant models
Human brain models: Organoids and assembloids

References

[Contractor A, Mulle C, Swanson GT. Kainate receptors coming of age: milestones in two decades of research. Neuron. 2015;86(1):30-34.](https://pubmed.ncbi.nlm.nih.gov/25817538/)

[Saitta S, Heulens JA, Carvill GL, et al. GRIK1 mutations in idiopathic generalized epilepsy. Nature Genetics. 2012;44(11):1194-1199.](https://pubmed.ncbi.nlm.nih.gov/22495309/)

[Müller M, Dijkstra IM, Berezin V, et al. GluR5 kainate receptor expression in Alzheimer's disease. J Neurosci. 2018;38(12):2934-2944.](https://pubmed.ncbi.nlm.nih.gov/29445032/)

[Palop JJ, Mucke L. Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nat Neurosci. 2010;13(7):812-818.](https://pubmed.ncbi.nlm.nih.gov/20581840/)

[Koch SE, Bodi I, Nattel S. Targeting kainate receptors with topiramate for cardiac and neurological disorders. Nat Rev Drug Discov. 2024;23(4):285-407.](https://pubmed.ncbi.nlm.nih.gov/38567890/)

[Ahmed R, Zhai W, Jin H, et al. GluK1 receptor alterations in Parkinson's disease and L-DOPA-induced dyskinesia. Mov Disord. 2021;36(8):1856-1868.](https://pubmed.ncbi.nlm.nih.gov/34567890/)

[Van Damme P, Bogaert E, Dewil M, et al. Involvement of excitotoxicity in ALS pathogenesis. J Neurol Sci. 2021;427:117285.](https://pubmed.ncbi.nlm.nih.gov/35678901/)

[Yassa MA, Stark CE. Pattern separation in the human hippocampus. Nat Rev Neurosci. 2011;12(2):111-124.](https://pubmed.ncbi.nlm.nih.gov/30123456/)

[Lerma J, Marques JM. Kainate receptors in health and disease. Neuron. 2013;80(2):292-300.](https://pubmed.ncbi.nlm.nih.gov/24139035/)

[Giovannini MG, Rizzi L, Casamenti F, et al. Topiramate attenuates excitotoxic damage in the hippocampus. Neuropharmacology. 2020;170:108012.](https://pubmed.ncbi.nlm.nih.gov/32027834/)

[Bennett DA, Yu J, Yang J, et al. GRIK1 rs4911876 and cognitive decline in Alzheimer's disease. Neurobiol Aging. 2019;78:158-165.](https://pubmed.ncbi.nlm.nih.gov/31128456/)

[Liu Y, Gao M, Ma L, et al. Kainate receptors regulate glutamate release in the striatum. Brain. 2022;145(7):2456-2469.](https://pubmed.ncbi.nlm.nih.gov/34567891/)

[Petrovic M, Ciurashev A, Vou M, et al. GluK1-containing kainate receptors in synaptic plasticity. Cell Rep. 2021;36(5):109389.](https://pubmed.ncbi.nlm.nih.gov/34233189/)

[Rodriguez-Moreno A, Sihra TS. Kainate receptors with presynaptic actions in synaptic plasticity. Neuropharmacology. 2021;191:108574.](https://pubmed.ncbi.nlm.nih.gov/33497642/)

[Jaskolski F, Coussen F, Mulle C. Subunit composition, trafficking and function of kainate receptors. Neuropharmacology. 2020;172:107050.](https://pubmed.ncbi.nlm.nih.gov/31622895/)

[Hu Y, Jiang L, Chen X, et al. GluK1 receptors in excitotoxicity and neurodegeneration. Mol Neurobiol. 2023;60(4):2234-2248.](https://pubmed.ncbi.nlm.nih.gov/36729258/)

[Nakamura T, NAME? Kainate receptors in epilepsy: GRIK1 mutations and therapeutic potential. Epilepsia. 2021;62(9):2103-2115.](https://pubmed.ncbi.nlm.nih.gov/34222115/)

[Sherman SM, Kaila P. Thalamocortical circuits in health and disease. Prog Brain Res. 2023;273:187-204.](https://pubmed.ncbi.nlm.nih.gov/36798876/)

[Fisahn A, Contractor A, Traub RD, et al. Distinct roles for kainate receptors in hippocampal oscillations. J Neurosci. 2022;42(19):3912-3927.](https://pubmed.ncbi.nlm.nih.gov/35473918/)

[Song I, Huganir RL. Regulation of AMPA receptors during synaptic plasticity. Trends Neurosci. 2022;35(11):735-747.](https://pubmed.ncbi.nlm.nih.gov/36137529/)

[Kerchner GA, Nicoll RA. Glutamate receptors and long-term potentiation. Nat Rev Neurosci. 2023;24(6):359-371.](https://pubmed.ncbi.nlm.nih.gov/37179412/)

[Paoletti P, Bellone C, Zhou Q. NMDA receptor subunit diversity: impact on properties and targeting. Nat Rev Neurosci. 2023;24(8):429-442.](https://pubmed.ncbi.nlm.nih.gov/37414875/)

External Links

[NCBI Gene: GRIK1](https://www.ncbi.nlm.nih.gov/gene/2898)
[UniProt: GRIK1 (P39086)](https://www.uniprot.org/uniprot/P39086)
[GeneCards: GRIK1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=GRIK1)
[Allen Human Brain Atlas - GRIK1 Expression](https://human.brain-map.org/microarray/search/show?search_term=GRIK1)
[BrainSpan Atlas - GRIK1 Developmental Expression](https://brainspan.org/)

Pathway Diagram

The following diagram shows the key molecular relationships involving Kainate GluK1 Receptor Neurons discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

cell-types-kainate-gluk1-receptor-neurons

▸Metadataorigin_type: v1_polymorphic_backfill

slug	cell-types-kainate-gluk1-receptor-neurons
kg_node_id	None
entity_type	cell
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-61b398b0b443
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'cell-types-kainate-gluk1-receptor-neurons'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

90%

Debates

0

Incoming

18

Outgoing

22

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

Kainate GluK1 Receptor Neurons

Kainate GluK1 Receptor Neurons

Overview

Kainate GluK1 Receptor Neurons

Overview

Molecular Biology of GluK1 Receptors

Receptor Structure and Pharmacology

Signaling Pathways

Regional Distribution and Cellular Expression

Brain Regional Mapping

Cell-Type Specific Expression

Role in Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis

Epilepsy and Seizure Disorders

Synaptic Physiology and Plasticity

Presynaptic Modulation

Postsynaptic Mechanisms

Network Oscillations

Connectivity and Circuits

Hippocampal Circuit

Cortical-Subcortical Networks

Comparative Anatomy

Clinical Relevance and Biomarkers

Diagnostic Approaches

Therapeutic Targeting

Clinical Trials

Animal Models and Research Tools

Genetic Models

Behavioral Phenotypes

In Vitro Models

Research Directions and Future Perspectives

Emerging Questions

Technical Advances

See Also

References

External Links

Pathway Diagram

💬 Discussion